Protara Therapeutics, Inc.

NasdaqGM:TARA Stock Report

Market Cap: US$53.6m

Protara Therapeutics Management

Management criteria checks 3/4

Protara Therapeutics' CEO is Jesse Shefferman, appointed in Jan 2020, has a tenure of 4.83 years. total yearly compensation is $1.91M, comprised of 31.9% salary and 68.1% bonuses, including company stock and options. directly owns 4.01% of the company’s shares, worth $2.15M. The average tenure of the management team and the board of directors is 2.8 years and 4.8 years respectively.

Key information

Jesse Shefferman

Chief executive officer

US$1.9m

Total compensation

CEO salary percentage31.9%
CEO tenure4.8yrs
CEO ownership4.0%
Management average tenure2.8yrs
Board average tenure4.8yrs

Recent management updates

Recent updates

Here's Why We're Watching Protara Therapeutics' (NASDAQ:TARA) Cash Burn Situation

Nov 22
Here's Why We're Watching Protara Therapeutics' (NASDAQ:TARA) Cash Burn Situation

Is Protara Therapeutics (NASDAQ:TARA) In A Good Position To Invest In Growth?

Aug 08
Is Protara Therapeutics (NASDAQ:TARA) In A Good Position To Invest In Growth?

Protara: A Bombed Out Biotech With A Very Positive Skew

Feb 22

Here's Why We're Watching Protara Therapeutics' (NASDAQ:TARA) Cash Burn Situation

Dec 16
Here's Why We're Watching Protara Therapeutics' (NASDAQ:TARA) Cash Burn Situation

We Think Protara Therapeutics (NASDAQ:TARA) Can Afford To Drive Business Growth

Apr 22
We Think Protara Therapeutics (NASDAQ:TARA) Can Afford To Drive Business Growth

The Prognosis For Protara Therapeutics

Oct 13

Here's Why We're Not Too Worried About Protara Therapeutics' (NASDAQ:TARA) Cash Burn Situation

Sep 12
Here's Why We're Not Too Worried About Protara Therapeutics' (NASDAQ:TARA) Cash Burn Situation

Will Protara Therapeutics (NASDAQ:TARA) Spend Its Cash Wisely?

Mar 21
Will Protara Therapeutics (NASDAQ:TARA) Spend Its Cash Wisely?

Is Protara Therapeutics (NASDAQ:TARA) In A Good Position To Deliver On Growth Plans?

Dec 06
Is Protara Therapeutics (NASDAQ:TARA) In A Good Position To Deliver On Growth Plans?

CEO Compensation Analysis

How has Jesse Shefferman's remuneration changed compared to Protara Therapeutics's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

-US$42m

Jun 30 2024n/an/a

-US$41m

Mar 31 2024n/an/a

-US$42m

Dec 31 2023US$2mUS$608k

-US$40m

Sep 30 2023n/an/a

-US$69m

Jun 30 2023n/an/a

-US$67m

Mar 31 2023n/an/a

-US$64m

Dec 31 2022US$3mUS$588k

-US$66m

Sep 30 2022n/an/a

-US$37m

Jun 30 2022n/an/a

-US$40m

Mar 31 2022n/an/a

-US$45m

Dec 31 2021US$4mUS$570k

-US$47m

Sep 30 2021n/an/a

-US$46m

Jun 30 2021n/an/a

-US$43m

Mar 31 2021n/an/a

-US$37m

Dec 31 2020US$8mUS$507k

-US$34m

Sep 30 2020n/an/a

-US$28m

Jun 30 2020n/an/a

-US$22m

Mar 31 2020n/an/a

-US$16m

Dec 31 2019US$379kUS$344k

-US$8m

Sep 30 2019n/an/a

-US$7m

Dec 31 2018US$301kUS$268k

-US$4m

Compensation vs Market: Jesse's total compensation ($USD1.91M) is above average for companies of similar size in the US market ($USD647.72K).

Compensation vs Earnings: Jesse's compensation has been consistent with company performance over the past year.


CEO

Jesse Shefferman (52 yo)

4.8yrs

Tenure

US$1,906,132

Compensation

Mr. Jesse Shefferman serves as Chief Executive Officer, President and Director of Protara Therapeutics, Inc. (Formerly known as Proteon Therapeutics Inc.) since January 2020. He Co-founded Protara Therapeu...


Leadership Team

NamePositionTenureCompensationOwnership
Jesse Shefferman
Co-founder4.8yrsUS$1.91m4.01%
$ 2.2m
Jacqueline Zummo
Co-Founder3.8yrsUS$1.04m0.31%
$ 164.7k
Patrick Fabbio
Chief Financial Officer1.8yrsUS$1.44m0%
$ 0
Hannah Fry
VP, Principal Accounting Officer & Controller2.3yrsno data0.083%
$ 44.3k
Justine O'Malley
Senior Vice President of Investor Relations & Corporate Affairs2.8yrsno datano data
Mary Grendell
General Counsel & Corporate Secretary2.8yrsno datano data

2.8yrs

Average Tenure

47.5yo

Average Age

Experienced Management: TARA's management team is considered experienced (2.8 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Jesse Shefferman
Co-founder4.8yrsUS$1.91m4.01%
$ 2.2m
Luke Beshar
Independent Chairman of the Board6.1yrsUS$192.26k0.15%
$ 78.0k
Richard Levy
Independent Director4.8yrsUS$118.26k0.15%
$ 80.6k
Gregory Sargen
Independent Director4.8yrsUS$75.76k0%
$ 0
Michael Solomon
Independent Director4.8yrsUS$71.76k0%
$ 0
Roger Garceau
Independent Director4.8yrsUS$91.76k0%
$ 0
Cynthia Smith
Independent Director3.8yrsUS$72.76k0%
$ 0
Barry Flannelly
Independent Director4.3yrsUS$66.76k0%
$ 0
Edna Huang
Independent Director3.4yrsUS$85.76k0%
$ 0

4.8yrs

Average Tenure

58yo

Average Age

Experienced Board: TARA's board of directors are considered experienced (4.8 years average tenure).